62140-78-7

Basic information

• Product Name: 7-NITRO-2,3-DIHYDRO-BENZO[1,4]DIOXIN-6-YLAMINE
• Synonyms: 7-Nitro-2,3-dihydro-1,4-benzodioxin-6-amine;6-Nitro-2,3-dihydro-1,4-benzodioxin-7-amine
• CAS NO: 62140-78-7
• Molecular Formula: C₈H₈N₂O₄
• Molecular Weight: 196.16
• Mol File: 62140-78-7.mol
• Article Data: 5

Chemical Properties

• Boiling Point: 382.4 °C at 760 mmHg
• Flash Point: 185.1 °C
• Appearance: /
• Density: 1.48 g/cm³
• Vapor Pressure: 4.74E-06mmHg at 25°C
• Refractive Index: 1.641
• CAS DataBase Reference: 7-NITRO-2,3-DIHYDRO-BENZO[1,4]DIOXIN-6-YLAMINE(CAS DataBase Reference)
• NIST Chemistry Reference: 7-NITRO-2,3-DIHYDRO-BENZO[1,4]DIOXIN-6-YLAMINE(62140-78-7)
• EPA Substance Registry System: 7-NITRO-2,3-DIHYDRO-BENZO[1,4]DIOXIN-6-YLAMINE(62140-78-7)

Safety Data

• Hazardous Substances Data: 62140-78-7(Hazardous Substances Data)

Usage

General Description

7-NITRO-2,3-DIHYDRO-BENZO[1,4]DIOXIN-6-YLAMINE is a chemical compound with the molecular formula C8H7N3O4. It belongs to the class of organic compounds known as nitrobenzenes, which are compounds containing a nitro group attached to a benzene ring. This chemical is a yellow solid that is used in research and chemical synthesis. It is also known by its chemical name 7-nitro-2,3-dihydro-1,4-benzodioxin-6-amine. 7-NITRO-2,3-DIHYDRO-BENZO[1,4]DIOXIN-6-YLAMINE has potential applications in the development of pharmaceuticals and agrochemicals due to its diverse range of properties and reactivity.

InChI:InChI=1/C8H8N2O4/c9-5-3-7-8(14-2-1-13-7)4-6(5)10(11)12/h3-4H,1-2,9H2

Upstream product

• 22013-33-8 6-amino-3,4-benzodioxane 
• 57356-48-6 6,7-dinitro-2,3-dihydrobenzo[1,4]dioxine 
• 493-09-4 benzo-1,4-dioxane 
• 63546-19-0 N-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)acetamide 
• 59820-92-7 6-bromo-7-nitro-2,3-dihydrobenzo[b][1,4]dioxine 
• 475112-04-0 6-benzylamino-7-nitro-2,3-dihydro-1,4-benzodioxine 
• 63546-22-5 6-acetamido-7-nitro-2,3-dihydro-1,4-benzodioxine 

Downstream Products

• 22013-33-8 6-amino-3,4-benzodioxane 
• 81927-47-1 7-amino-2,3-dihydro-1,4-benzodioxin-6-ylamine 
• 81864-47-3 6,7-dihydro-1H-[1,4]dioxino[2',3':4,5]benzo[d]imidazole-2-thiol 
• 415911-31-8 2-{4-[(7-nitro-2,3-dihydro-1,4-benzodioxin-6-yl)amino]phenyl}ethanol 
• 1338684-45-9 12-(3-phenylpropyl)-8,9-dihydro[1,4]benzodioxino[6,7-g]pteridine-2,4(3H,12H)-dione 
• 1178618-47-7 N-(3-phenylpropyl)-2,3-dihydro-1,4-benzodioxine-6,7-diamine 
• 1338684-46-0 7-nitro-N-(3-phenylpropyl)-2,3-dihydro-1,4-benzodioxin-6-amine 
• 59820-92-7 6-bromo-7-nitro-2,3-dihydrobenzo[b][1,4]dioxine 

Relevant articles and documents

Quinoxaline compound, preparation method and application of quinoxaline compound in medicine

The invention provides a quinoxaline compound, a preparation method and application of the quinoxaline compound in medicine, and particularly relates to a quinoxaline compound with PAR4 antagonistic activity, a preparation method of the quinoxaline compound, a pharmaceutical composition containing the quinoxaline compound and application of the quinoxaline compound. Specifically, the invention provides a compound shown as a general formula I and/or II or a tautomer or pharmaceutically acceptable salt thereof, a preparation method of the compound, and application of the compound or the tautomer or the pharmaceutically acceptable salt in medicines for preventing and/or treating thromboembolic diseases.

Use of EP4 receptor ligands in the treatment of IL-6 involved diseases

Methods of treating IL-6 involved diseases with EP4 receptor ligands, including EP4 receptor antagonists. Assays to determine the effect of test compounds on PGE2-induced whole blood cells activation.

EP4 RECEPTOR INHIBITORS TO TREAT RHEUMATOID ARTHRITIS

The invention features a method of treating rheumatoid arthritis in a mammal comprising administering an agent that inhibits prostaglandin EP4 receptor (EP4) activity. Also featured is a method of identifying agents that selectively inhibit EP4 activity in vivo.